Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice.

PubWeight™: 1.15‹?› | Rank: Top 10%

🔗 View Article (PMC 2546978)

Published in J Virol on July 16, 2008

Authors

Lorena Garaicoechea1, Aurelien Olichon, Gisela Marcoppido, Andrés Wigdorovitz, Marina Mozgovoj, Linda Saif, Thomas Surrey, Viviana Parreño

Author Affiliations

1: Instituto de Virología, CICV y A-INTA, CC 25 (1712) Castelar, Buenos Aires, Argentina. lgaraicoechea@cnia.inta.gov.ar

Articles citing this

Rice-based oral antibody fragment prophylaxis and therapy against rotavirus infection. J Clin Invest (2013) 2.15

Single domain antibodies: promising experimental and therapeutic tools in infection and immunity. Med Microbiol Immunol (2009) 1.94

Llama antibody fragments with cross-subtype human immunodeficiency virus type 1 (HIV-1)-neutralizing properties and high affinity for HIV-1 gp120. J Virol (2008) 1.71

Immune responses to rotavirus infection and vaccination and associated correlates of protection. J Infect Dis (2011) 1.20

Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules. PLoS One (2011) 1.20

Neutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domain. J Biol Chem (2011) 1.19

Biotechnological applications of recombinant single-domain antibody fragments. Microb Cell Fact (2011) 1.16

Generation of a family-specific phage library of llama single chain antibody fragments that neutralize HIV-1. J Biol Chem (2010) 0.98

In vitro neutralisation of rotavirus infection by two broadly specific recombinant monovalent llama-derived antibody fragments. PLoS One (2012) 0.89

Toxin-specific antibodies for the treatment of Clostridium difficile: current status and future perspectives. Toxins (Basel) (2010) 0.88

Translational fusion and redirection to thylakoid lumen as strategies to improve the accumulation of a camelid antibody fragment in transplastomic tobacco. Planta (2012) 0.87

Comparative immunogenicity in mice of rotavirus VP6 tubular structures and virus-like particles. Hum Vaccin Immunother (2013) 0.84

Immune responses elicited against rotavirus middle layer protein VP6 inhibit viral replication in vitro and in vivo. Hum Vaccin Immunother (2014) 0.83

Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea. PLoS Pathog (2013) 0.82

The breadth of cross sub-type neutralisation activity of a single domain antibody to influenza hemagglutinin can be increased by antibody valency. PLoS One (2014) 0.82

Rotavirus A-specific single-domain antibodies produced in baculovirus-infected insect larvae are protective in vivo. BMC Biotechnol (2012) 0.82

Identification of cellular calcium binding protein calmodulin as a regulator of rotavirus A infection during comparative proteomic study. PLoS One (2013) 0.81

Sang Froid in a time of trouble: is a vaccine against HIV possible? J Int AIDS Soc (2009) 0.81

Significant productivity improvement of the baculovirus expression vector system by engineering a novel expression cassette. PLoS One (2014) 0.79

Design and selection of a camelid single-chain antibody yeast two-hybrid library produced de novo for the cap protein of porcine circovirus type 2 (PCV2). PLoS One (2013) 0.79

An Exopolysaccharide-Deficient Mutant of Lactobacillus rhamnosus GG Efficiently Displays a Protective Llama Antibody Fragment against Rotavirus on Its Surface. Appl Environ Microbiol (2015) 0.79

Single domain antibody multimers confer protection against rabies infection. PLoS One (2013) 0.78

Novel camelid antibody fragments targeting recombinant nucleoprotein of Araucaria hantavirus: a prototype for an early diagnosis of Hantavirus Pulmonary Syndrome. PLoS One (2014) 0.77

Construction of a synthetic phage-displayed Nanobody library with CDR3 regions randomized by trinucleotide cassettes for diagnostic applications. J Transl Med (2014) 0.77

Rotavirus capsid VP6 protein acts as an adjuvant in vivo for norovirus virus-like particles in a combination vaccine. Hum Vaccin Immunother (2016) 0.76

Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus. Sci Rep (2016) 0.75

Design and Antigenic Epitopes Prediction of a New Trial Recombinant Multiepitopic Rotaviral Vaccine: In Silico Analyses. Viral Immunol (2015) 0.75

Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease. PLoS One (2016) 0.75

Llama nanoantibodies with therapeutic potential against human norovirus diarrhea. PLoS One (2015) 0.75

Articles cited by this

Rotavirus and severe childhood diarrhea. Emerg Infect Dis (2006) 7.80

By-passing immunization. Human antibodies from V-gene libraries displayed on phage. J Mol Biol (1991) 6.62

Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science (1988) 3.38

Selection and identification of single domain antibody fragments from camel heavy-chain antibodies. FEBS Lett (1997) 3.18

Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science (1996) 3.07

Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies. Proc Natl Acad Sci U S A (2006) 2.51

Systematic and intestinal antibody-secreting cell responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J Virol (1996) 2.25

Single domain camel antibodies: current status. J Biotechnol (2001) 2.24

Beta-lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob Agents Chemother (2001) 2.24

Occupancy and mechanism in antibody-mediated neutralization of animal viruses. J Gen Virol (2002) 2.21

Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol (1994) 2.03

Preliminary characterization of an epitope involved in neutralization and cell attachment that is located on the major bovine rotavirus glycoprotein. J Virol (1985) 1.97

Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from immunized or nonimmunized cows. Infect Immun (1983) 1.77

Analyses of homologous rotavirus infection in the mouse model. Virology (1995) 1.75

Immunization with baculovirus-expressed VP4 protein passively protects against simian and murine rotavirus challenge. J Virol (1990) 1.37

Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP6-specific IgA mAb. J Clin Invest (2002) 1.34

Lactobacilli expressing variable domain of llama heavy-chain antibody fragments (lactobodies) confer protection against rotavirus-induced diarrhea. J Infect Dis (2006) 1.31

Serum and intestinal isotype antibody responses and correlates of protective immunity to human rotavirus in a gnotobiotic pig model of disease. J Gen Virol (1998) 1.24

Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J Virol (2006) 1.22

Reduction in morbidity of rotavirus induced diarrhoea in mice by yeast produced monovalent llama-derived antibody fragments. Vaccine (2006) 1.20

Antibody-independent protection against rotavirus infection of mice stimulated by intranasal immunization with chimeric VP4 or VP6 protein. J Virol (1999) 1.18

Heterologous protection induced by the inner capsid proteins of rotavirus requires transcytosis of mucosal immunoglobulins. J Virol (2002) 1.18

Protective immunity induced by oral immunization with a rotavirus DNA vaccine encapsulated in microparticles. J Virol (1998) 1.18

Comparative structural analysis of transcriptionally competent and incompetent rotavirus-antibody complexes. Proc Natl Acad Sci U S A (1999) 1.12

Randomized, placebo-controlled, clinical trial of hyperimmunized chicken egg yolk immunoglobulin in children with rotavirus diarrhea. J Pediatr Gastroenterol Nutr (2001) 1.10

The production of antibody fragments and antibody fusion proteins by yeasts and filamentous fungi. Microb Cell Fact (2003) 1.07

Passive immunity to bovine rotavirus in newborn calves fed colostrum supplements from cows immunized with recombinant SA11 rotavirus core-like particle (CLP) or virus-like particle (VLP) vaccines. Vaccine (1998) 1.02

Selection of genetically encoded fluorescent single domain antibodies engineered for efficient expression in Escherichia coli. J Biol Chem (2007) 1.01

Passive immunization of guinea pigs with llama single-domain antibody fragments against foot-and-mouth disease. Vet Microbiol (2006) 0.99

Systemic and intestinal antibody secreting cell responses and protection in gnotobiotic pigs immunized orally with attenuated Wa human rotavirus and Wa 2/6-rotavirus-like-particles associated with immunostimulating complexes. Vaccine (2002) 0.97

Topology of bovine rotavirus (RF strain) VP6 epitopes by real-time biospecific interaction analysis. Virology (1994) 0.97

Murine model of rotavirus infection. Adv Exp Med Biol (1997) 0.97

Assembly of recombinant rotavirus proteins into virus-like particles and assessment of vaccine potential. Vaccine (1993) 0.97

A survey of G6 and G10 serotypes of group A bovine rotaviruses from diarrheic beef and dairy calves using monoclonal antibodies in ELISA. J Vet Diagn Invest (1994) 0.97

Nasal immunization of mice with virus-like particles protects offspring against rotavirus diarrhea. J Virol (2000) 0.97

Bovine milk antibodies for health. Br J Nutr (2000) 0.96

Protective immunity induced by rotavirus DNA vaccines. Vaccine (1997) 0.96

Escherichia coli F4 fimbriae specific llama single-domain antibody fragments effectively inhibit bacterial adhesion in vitro but poorly protect against diarrhoea. Vet Microbiol (2005) 0.95

Field evaluation of chicken egg yolk immunoglobulins specific for bovine rotavirus in neonatal calves. Arch Virol (1997) 0.92

Amino acid domains 280-297 of VP6 and 531-554 of VP4 are implicated in heat shock cognate protein hsc70-mediated rotavirus infection. Arch Virol (2007) 0.90

Passive protection against bovine rotavirus in calves by specific immunoglobulins from chicken egg yolk. Arch Virol (1994) 0.90

Development of a murine model to study the pathogenesis of rotavirus infection. Exp Mol Pathol (1989) 0.87

First isolation of rotavirus associated with neonatal diarrhoea in guanacos (Lama guanicoe) in the Argentinean Patagonia region. J Vet Med B Infect Dis Vet Public Health (2001) 0.87

Rotavirus-neutralizing antibodies inhibit virus binding to integrins alpha 2 beta 1 and alpha 4 beta 1. Arch Virol (2007) 0.86

Modulation by colostrum-acquired maternal antibodies of systemic and mucosal antibody responses to rotavirus in calves experimentally challenged with bovine rotavirus. Vet Immunol Immunopathol (2004) 0.84

Antibody-secreting cell responses to rotavirus proteins in gnotobiotic pigs inoculated with attenuated or virulent human rotavirus. J Clin Microbiol (2001) 0.83

Protection of mice against rotavirus challenge following intradermal DNA immunization by Biojector needle-free injection. Vaccine (2007) 0.82

Nasal immunisation with Salmonella typhimurium producing rotavirus VP2 and VP6 antigens stimulates specific antibody response in serum and milk but fails to protect offspring. Vaccine (2001) 0.82

Passive immunity against rotavirus in infants. Acta Paediatr Suppl (1999) 0.81

Isotypes of intestinal and systemic antibodies in colostrum-fed and colostrum-deprived calves challenged with rotavirus. Adv Exp Med Biol (1987) 0.80

Traffic of antibody-secreting cells after immunization with a liposome-associated, CpG-ODN-adjuvanted oral cholera vaccine. Asian Pac J Allergy Immunol (2006) 0.77

[Systemic availability of bovine immunoglobulin G and chicken immunoglobulin Y after feeding colostrum and whole egg powder to newborn calves]. Arch Tierernahr (1997) 0.77

Articles by these authors

Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol (2011) 3.87

Reconstitution of a microtubule plus-end tracking system in vitro. Nature (2007) 3.50

A minimal midzone protein module controls formation and length of antiparallel microtubule overlaps. Cell (2010) 2.63

Rotavirus antigenaemia and viraemia: a common event? Lancet (2003) 2.51

The pig: a model for human infectious diseases. Trends Microbiol (2011) 2.46

Thermal fluctuations of grafted microtubules provide evidence of a length-dependent persistence length. Proc Natl Acad Sci U S A (2006) 2.41

CLIP-170 tracks growing microtubule ends by dynamically recognizing composite EB1/tubulin-binding sites. J Cell Biol (2008) 2.31

EBs recognize a nucleotide-dependent structural cap at growing microtubule ends. Cell (2012) 2.24

Directional switching of the kinesin Cin8 through motor coupling. Science (2011) 2.06

GTPgammaS microtubules mimic the growing microtubule end structure recognized by end-binding proteins (EBs). Proc Natl Acad Sci U S A (2011) 1.79

Microtubule organization by the antagonistic mitotic motors kinesin-5 and kinesin-14. J Cell Biol (2010) 1.74

Are human P[14] rotavirus strains the result of interspecies transmissions from sheep or other ungulates that belong to the mammalian order Artiodactyla? J Virol (2009) 1.62

A kinesin-like motor inhibits microtubule dynamic instability. Science (2004) 1.57

Phosphorylation relieves autoinhibition of the kinetochore motor Cenp-E. Mol Cell (2008) 1.54

Processive movement of single kinesins on crowded microtubules visualized using quantum dots. EMBO J (2006) 1.51

Poleward transport of Eg5 by dynein-dynactin in Xenopus laevis egg extract spindles. J Cell Biol (2008) 1.49

Protein repellent properties of covalently attached PEG coatings on nanostructured SiO(2)-based interfaces. Biomaterials (2007) 1.44

Self-organisation and forces in the microtubule cytoskeleton. Curr Opin Cell Biol (2003) 1.35

Nucleotide-induced conformations in the neck region of dimeric kinesin. EMBO J (2003) 1.32

Phosphorylation by Cdk1 increases the binding of Eg5 to microtubules in vitro and in Xenopus egg extract spindles. PLoS One (2008) 1.28

Modelling microtubule patterns. Nat Cell Biol (2006) 1.25

Fluorescence microscopy assays on chemically functionalized surfaces for quantitative imaging of microtubule, motor, and +TIP dynamics. Methods Cell Biol (2010) 1.23

Obstacles on the microtubule reduce the processivity of Kinesin-1 in a minimal in vitro system and in cell extract. Biophys J (2009) 1.19

A designed ankyrin repeat protein selected to bind to tubulin caps the microtubule plus end. Proc Natl Acad Sci U S A (2012) 1.16

The parkinsonism producing neurotoxin MPP+ affects microtubule dynamics by acting as a destabilising factor. FEBS Lett (2005) 1.16

Development and biological evaluation of potent and specific inhibitors of mitotic Kinesin Eg5. Chembiochem (2005) 1.16

Synthesis and biological evaluation of new tetrahydro-beta-carbolines as inhibitors of the mitotic kinesin Eg5. Bioorg Med Chem (2005) 1.15

Reconstitution of the human cytoplasmic dynein complex. Proc Natl Acad Sci U S A (2012) 1.13

Drosophila ensconsin promotes productive recruitment of Kinesin-1 to microtubules. Dev Cell (2008) 1.09

Processive kinesins require loose mechanical coupling for efficient collective motility. EMBO Rep (2008) 1.07

End-binding proteins and Ase1/PRC1 define local functionality of structurally distinct parts of the microtubule cytoskeleton. Trends Cell Biol (2012) 1.02

Selection of genetically encoded fluorescent single domain antibodies engineered for efficient expression in Escherichia coli. J Biol Chem (2007) 1.01

IgY antibodies protect against human Rotavirus induced diarrhea in the neonatal gnotobiotic piglet disease model. PLoS One (2012) 1.01

Microtubule motility on reconstituted meiotic chromatin. Curr Biol (2010) 0.99

Aster migration determines the length scale of nuclear separation in the Drosophila syncytial embryo. J Cell Biol (2012) 0.96

A novel approach to indoloditerpenes by Nazarov photocyclization: synthesis and biological investigations of terpendole E analogues. Org Lett (2010) 0.96

Prevalence and molecular characterization of porcine enteric caliciviruses and first detection of porcine kobuviruses in US swine. Arch Virol (2013) 0.94

Phylogenetic analysis of porcine rotavirus in Argentina: increasing diversity of G4 strains and evidence of interspecies transmission. Vet Microbiol (2007) 0.93

Key factors for stable retention of fluorophores and labeled biomolecules in droplet-based microfluidics. Anal Chem (2015) 0.93

Motile microtubule crosslinkers require distinct dynamic properties for correct functioning during spindle organization in Xenopus egg extract. J Cell Sci (2009) 0.93

Complete genomic sequences, a key residue in the spike protein and deletions in nonstructural protein 3b of US strains of the virulent and attenuated coronaviruses, transmissible gastroenteritis virus and porcine respiratory coronavirus. Virology (2006) 0.93

Motor protein KIFC5A interacts with Nubp1 and Nubp2, and is implicated in the regulation of centrosome duplication. J Cell Sci (2006) 0.90

Complete molecular genome analyses of equine rotavirus A strains from different continents reveal several novel genotypes and a largely conserved genotype constellation. J Gen Virol (2011) 0.89

Efficacy of a BVDV subunit vaccine produced in alfalfa transgenic plants. Vet Immunol Immunopathol (2012) 0.89

Development of transgenic alfalfa plants containing the foot and mouth disease virus structural polyprotein gene P1 and its utilization as an experimental immunogen. Vaccine (2005) 0.88

Translational fusion and redirection to thylakoid lumen as strategies to improve the accumulation of a camelid antibody fragment in transplastomic tobacco. Planta (2012) 0.87

Microtubule gliding and cross-linked microtubule networks on micropillar interfaces. Nano Lett (2005) 0.86

Genomic characterization of a novel group A lamb rotavirus isolated in Zaragoza, Spain. Virus Genes (2008) 0.86

Microtubule organization in vitro. Curr Opin Cell Biol (2013) 0.86

Single domain antibodies with VH hallmarks are positively selected during panning of llama (Lama glama) naïve libraries. Dev Comp Immunol (2011) 0.86

Safety and efficacy of an E2 glycoprotein subunit vaccine produced in mammalian cells to prevent experimental infection with bovine viral diarrhoea virus in cattle. Vet Res Commun (2012) 0.83

Antibodies to pathogenic livestock viruses in a wild vicuña (Vicugna vicugna) population in the Argentinean Andean altiplano. J Wildl Dis (2010) 0.83

Recombinant monovalent llama-derived antibody fragments (VHH) to rotavirus VP6 protect neonatal gnotobiotic piglets against human rotavirus-induced diarrhea. PLoS Pathog (2013) 0.82

A novel methodology to develop a foot and mouth disease virus (FMDV) peptide-based vaccine in transgenic plants. Vaccine (2002) 0.82

Rotavirus A-specific single-domain antibodies produced in baculovirus-infected insect larvae are protective in vivo. BMC Biotechnol (2012) 0.82

A single Drosophila embryo extract for the study of mitosis ex vivo. Nat Protoc (2013) 0.82

High expression level of a foot and mouth disease virus epitope in tobacco transplastomic plants. Planta (2009) 0.81

Micropattern-controlled local microtubule nucleation, transport, and mesoscale organization. ACS Chem Biol (2013) 0.81

Brucella spp. lumazine synthase as a bovine rotavirus antigen delivery system. Vaccine (2008) 0.80

Discovery and molecular characterization of a group A rotavirus strain detected in an Argentinean vicuña (Vicugna vicugna). Vet Microbiol (2012) 0.80

Isolation and characterization of bovine parainfluenza virus type 3 from water buffaloes (Bubalus bubalis) in Argentina. BMC Vet Res (2012) 0.80

Reconstitution and quantification of dynamic microtubule end tracking in vitro using TIRF microscopy. Methods Mol Biol (2011) 0.80

Organization of motor proteins into functional micropatterns fabricated by a photoinduced Fenton reaction. Angew Chem Int Ed Engl (2009) 0.79

Phototriggerable 2',7-caged paclitaxel. PLoS One (2012) 0.79

The multiple talents of kinesin-8. Nat Cell Biol (2013) 0.78

Evaluation of a bovine rotavirus VP6 vaccine efficacy in the calf model of infection and disease. Vet Immunol Immunopathol (2010) 0.78

Molecular characterization of equine rotaviruses circulating in Argentinean foals during a 17-year surveillance period (1992-2008). Vet Microbiol (2010) 0.78

Validation of an indirect ELISA to detect antibodies against BoHV-1 in bovine and guinea-pig serum samples using ISO/IEC 17025 standards. J Virol Methods (2010) 0.77

LIS1 clamps dynein to the microtubule. Cell (2012) 0.77

Transgenic plants for the production of veterinary vaccines. Immunol Cell Biol (2005) 0.77

Protective lactogenic immunity conferred by an edible peptide vaccine to bovine rotavirus produced in transgenic plants. J Gen Virol (2004) 0.76

Transient gene expression in serum-free suspension-growing mammalian cells for the production of foot-and-mouth disease virus empty capsids. PLoS One (2013) 0.75

Corrigendum: Complementary activities of TPX2 and chTOG constitute an efficient importin-regulated microtubule nucleation module. Nat Cell Biol (2015) 0.75

Seeded microtubule growth for cryoelectron microscopy of end-binding proteins. Methods Mol Biol (2014) 0.75

Development of a PCR to diagnose BLV genome in frozen semen samples. Vet Microbiol (2006) 0.75

Simple procedures to obtain exogenous internal controls for use in RT-PCR detection of bovine pestiviruses. Mol Cell Probes (2008) 0.75

Molecular identification of Sarcocystis aucheniae as the macrocyst-forming parasite of llamas. Vet Parasitol (2013) 0.75

Detection of fiber-digesting bacteria in the forestomach contents of llamas (Lama glama) by PCR. Rev Argent Microbiol (2013) 0.75